Journal of Internal Medicine Concepts & Practice ›› 2023, Vol. 18 ›› Issue (04): 256-260.doi: 10.16138/j.1673-6087.2023.04.009
• Expert forum • Previous Articles Next Articles
ZHANG Jie, LU Jieli(
)
Received:2023-05-15
Online:2023-08-30
Published:2024-01-09
CLC Number:
ZHANG Jie, LU Jieli. Clinical diagnosis and treatment progress of hypoglycemia caused by non-islet cell tumors[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 256-260.
| [1] |
de Groot JW, Rikhof B, van Doorn J, et al. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases[J]. Endocr Relat Cancer, 2007, 14(4): 979-993.
doi: 10.1677/ERC-07-0161 URL |
| [2] | Baldwin RS. Hypoglycemia with neoplasia (doege-potter syndrome)[J]. Wis Med J, Wis Med J, 1965, 64: 185-189. |
| [3] |
Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review[J]. J Clin Endocrinol Metab, 2014, 99(3): 713-722.
doi: 10.1210/jc.2013-3382 pmid: 24423303 |
| [4] |
Fukuda I, Hizuka N, Ishikawa Y, et al. Clinical features of insulin-like growth factor-Ⅱ producing non-islet-cell tumor hypoglycemia[J]. Growth Horm IGF Res, 2006, 16(4): 211-216.
doi: 10.1016/j.ghir.2006.05.003 pmid: 16860583 |
| [5] | Rastogi MV, Desai N, Quintos JB. Non-islet-cell tumor hypoglycemia and lactic acidosis in a child with congenital HIV and Burkitt’s lymphoma[J]. J Pediatr Endocrinol Metab, 2008, 21(8): 805-810. |
| [6] |
Agus MS, Katz LE, Satin-Smith M, et al. Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone[J]. J Pediatr, 1995, 127(3): 403-407.
doi: 10.1016/S0022-3476(95)70071-4 URL |
| [7] |
Korn E, Van Hoff J, Buckley P, et al. Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor[J]. Med Pediatr Oncol, 1995, 24(6): 392-396.
pmid: 7715546 |
| [8] |
Teale JD, Marks V. Glucocorticoid therapy suppresses abnormal secretion of big IGF-Ⅱ by non-islet cell tumours inducing hypoglycaemia(NICTH)[J]. Clin Endocrinol (Oxf), 1998, 49(4): 491-498.
doi: 10.1046/j.1365-2265.1998.00564.x URL |
| [9] |
Phillips LS, Robertson DG. Insulin-like growth factors and non-islet cell tumor hypoglycemia[J]. Metabolism, 1993, 42(9): 1093-1101.
doi: 10.1016/0026-0495(93)90265-P URL |
| [10] | 陆洁莉, 赵咏桔, 唐金凤, 等. 胰岛素样生长因子Ⅱ过度分泌引起的非胰岛细胞肿瘤性低血糖——2例报告与文献复习[J]. 中华内分泌代谢杂志, 2004, 20(3): 234-235. |
| [11] | 陆洁莉, 刘建民, 方文强, 等. 非胰岛细胞肿瘤所致低血糖一例及文献复习[J]. 中华内分泌代谢杂志, 2016, 32(4): 330-334. |
| [12] |
Shapiro ET, Bell GI, Polonsky KS, et al. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-Ⅱ[J]. J Clin Invest, 1990, 85(5): 1672-1679.
doi: 10.1172/JCI114619 pmid: 2159026 |
| [13] | Rosseel L, De Leu N, van Hecke W, et al. A rare case of hypoglycemia in a patient with elevated right hemidiaphragm[J]. BMJ Case Rep, 2012, 2012: bcr0320125972. |
| [14] |
Zafar H, Takimoto CH, Weiss G. Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor[J]. Med Oncol, 2003, 20(4): 403-408.
pmid: 14716039 |
| [15] |
Dynkevich Y, Rother KI, Whitford I, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive[J]. Endocr Rev, 2013, 34(6): 798-826.
doi: 10.1210/er.2012-1033 pmid: 23671155 |
| [16] |
Kalebi AY, Hale MJ, Wong ML, et al. Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome[J]. J Cardiothorac Surg, 2009, 4: 45.
doi: 10.1186/1749-8090-4-45 pmid: 19689813 |
| [17] |
Daughaday WH, Emanuele MA, Brooks MH, et al. Synthesis and secretion of insulin-like growth factor Ⅱ by a leiomyosarcoma with associated hypoglycemia[J]. N Engl J Med, 1988, 319(22): 1434-1440.
doi: 10.1056/NEJM198812013192202 URL |
| [18] |
Baxter RC. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia[J]. Horm Res, 1996, 46(4-5): 195-201.
doi: 10.1159/000185023 pmid: 8950621 |
| [19] |
Bertherat J, Logié A, Gicquel C, et al. Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH)[J]. Clin Endocrinol (Oxf), 2000, 53(2): 213-220.
doi: 10.1046/j.1365-2265.2000.01064.x URL |
| [20] |
Tani Y, Tateno T, Izumiyama H, et al. Defective expression of prohormone convertase 4 and enhanced expression of insulin-like growth factor Ⅱ by pleural solitary fibrous tumor causing hypoglycemia[J]. Endocr J, 2008, 55(5): 905-911.
doi: 10.1507/endocrj.K08E-062 URL |
| [21] |
Hoekman K, van Doorn J, Gloudemans T, et al. Hypoglycaemia associated with the production of insulin-like growth factor Ⅱ and insulin-like growth factor binding protein 6 by a haemangiopericytoma[J]. Clin Endocrinol (Oxf), 1999, 51(2): 247-253.
doi: 10.1046/j.1365-2265.1999.00833.x URL |
| [22] |
Zachariah S, Brackenridge A, Shojaee-Moradie F, et al. The mechanism of non-islet cell hypoglycaemia caused by tumour-produced IGF-Ⅱ[J]. Clin Endocrinol (Oxf), 2007, 67(4): 637-638.
doi: 10.1111/cen.2007.67.issue-4 URL |
| [23] |
LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer[J]. Cancer Lett, 2003, 195(2): 127-137.
doi: 10.1016/s0304-3835(03)00159-9 pmid: 12767520 |
| [24] |
Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2009, 94(3): 709-728.
doi: 10.1210/jc.2008-1410 pmid: 19088155 |
| [25] |
Kageyama K, Moriyama T, Hizuka N, et al. Hypoglycemia associated with big insulin-like growth factor Ⅱ produced during development of malignant fibrous histiocytoma[J]. Endocr J, 2003, 50(6): 753-758.
doi: 10.1507/endocrj.50.753 URL |
| [26] |
Tsuro K, Kojima H, Okamoto S, et al. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-Ⅱ-producing solitary fibrous tumor[J]. Intern Med, 2006, 45(8): 525-529.
doi: 10.2169/internalmedicine.45.1611 URL |
| [27] |
Bessell EM, Selby C, Ellis IO. Severe hypoglycaemia caused by raised insulin-like growth factor Ⅱ in disseminated breast cancer[J]. J Clin Pathol, 1999, 52(10): 780-781.
doi: 10.1136/jcp.52.10.780 pmid: 10674040 |
| [28] |
Escobar GA, Robinson WA, Nydam TL, et al. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation[J]. BMC Cancer, 2007, 7: 13.
doi: 10.1186/1471-2407-7-13 URL |
| [29] | Barra WF, Castro G, Hoff AO, et al. Symptomatic hypoglycemia related to inappropriately high IGF-Ⅱ serum levels in a patient with desmoplastic small round cell tumor[J]. Case Rep Med, 2010, 2010: 684045. |
| [30] |
Hunter SJ, Daughaday WH, Callender ME, et al. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-Ⅱ(E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin[J]. Clin Endocrinol (Oxf), 1994, 41(3): 397-401.
doi: 10.1111/cen.1994.41.issue-3 URL |
| [31] |
Kishi K, Sonomura T, Sato M. Radiotherapy for hypoglycaemia associated with large leiomyosarcomas[J]. Br J Radiol, 1997, 70: 306-308.
doi: 10.1259/bjr.70.831.9166058 URL |
| [32] |
Teale JD, Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia[J]. Clin Endocrinol (Oxf), 2004, 60(4): 457-460.
doi: 10.1111/cen.2004.60.issue-4 URL |
| [33] |
Powter L, Phillips S, Husbands E. A case report of non-islet cell tumour hypoglycaemia associated with ovarian germ-cell tumour[J]. Palliat Med, 2013, 27(3): 281-283.
doi: 10.1177/0269216312462273 pmid: 23128903 |
| [34] |
Mukherjee S, Diver M, Weston PJ. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor[J]. Acta Oncol, 2005, 44(7): 761-763.
pmid: 16227169 |
| [35] |
Perros P, Simpson J, Innes JA, et al. Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids[J]. Clin Endocrinol (Oxf), 1996, 44(6): 727-731.
doi: 10.1046/j.1365-2265.1996.721542.x URL |
| [36] |
Silveira LF, Bouloux PM, MacColl GS, et al. Growth hormone therapy for non-islet cell tumor hypoglycemia[J]. Am J Med, 2002, 113(3): 255-257.
pmid: 12208393 |
| [37] | Teale JD, Blum WF, Marks V. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3[J]. Ann Clin Biochem, 1992, 29 Pt 3: 314-323. |
| [38] |
Drake WM, Miraki F, Siddiqi A, et al. Dose-related effects of growth hormone on IGF-Ⅰ and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia[J]. Eur J Endocrinol, 1998, 139(5): 532-536.
pmid: 9849819 |
| [39] |
Bourcigaux N, Arnault-Ouary G, Christol R, et al. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia[J]. Clin Ther, 2005, 27(2): 246-251.
doi: 10.1016/j.clinthera.2005.02.004 pmid: 15811488 |
| [40] | Baxter RC, Holman SR, Corbould A, et al. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia[J]. J Clin Endocrinol Metab, 1995, 80(9): 2700-2708. |
| [41] | Sullivan DH, Carter WJ, Warr WR, et al. Side effects resulting from the use of growth hormone and insulin-like growth factor-Ⅰ as combined therapy to frail elderly patients[J]. J Gerontol A Biol Sci Med Sci, 1998, 53(3): M183-M187. |
| [42] | Scott K. Non-islet cell tumor hypoglycemia[J]. J Pain Symptom Manage, 2009, 37(4): e1-e3. |
| [43] |
Föger B, Zapf J, Lechleitner M, et al. Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased ‘big’ insulin-like growth factor Ⅱ[J]. J Intern Med, 1994, 236(6): 692-693.
pmid: 7989907 |
| [44] |
Goode PN, Farndon JR, Anderson J, et al. Diazoxide in the management of patients with insulinoma[J]. World J Surg, 1986, 10(4): 586-592.
pmid: 3019020 |
| [45] |
Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: case report and a review of published studies[J]. Clin Oncol (R Coll Radiol), 2007, 19(4): 265-268.
doi: 10.1016/j.clon.2006.12.008 URL |
| [46] |
Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: case report and a review of published studies[J]. Clin Oncol (R Coll Radiol), 2007, 19(4): 265-268.
doi: 10.1016/j.clon.2006.12.008 URL |
| [47] |
Sturrock ND, Selby C, Hosking DJ. Spontaneous hypoglycaemia in a noninsulin-dependent diabetes mellitus patient with disseminated pancreatic carcinoma[J]. Diabet Med, 1997, 14(4): 324-326.
doi: 10.1002/(ISSN)1096-9136 URL |
| [48] | Krishnan L, Clark J. Non-islet cell tumour hypoglycaemia[J]. BMJ Case Rep, 2011, 2011: bcr0220113914. |
| [49] | Ishikura K, Takamura T, Takeshita Y, et al. Cushing’s syndrome and big IGF-Ⅱ associated hypoglycaemia in a patient with adrenocortical carcinoma[J]. BMJ Case Rep, 2010, 2010: bcr07. |
| [50] |
Morbois-Trabut L, Maillot F, De Widerspach-Thor A, et al. “Big IGF-Ⅱ”-induced hypoglycemia secondary to gastric adenocarcinoma[J]. Diabetes Metab, 2004, 30(3): 276-279.
doi: 10.1016/S1262-3636(07)70119-2 pmid: 15223980 |
| [1] | NING Guang. Precision treatment in endocrine tumors [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 225-226. |
| [2] | YE Lei, WANG Weiqing. Establishment and application of molecular diagnostic platform for endocrine tumors [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 227-229. |
| [3] | ZHANG Jie, BI Yufang. Metabolic risk factors for development of neuroendocrine tumors [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 251-255. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
